Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Kuijer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Cancer|December 16, 2022
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de-escalating approachJulia E C van Steenhoven, Marissa C van Maaren, Eline E F Verreck, et al.
Breast Cancer Research and Treatment|May 21, 2020
Patients' perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflictJulia E C van Steenhoven, Bianca M den Dekker, Anne Kuijer, et al.
Annals of Surgery|July 26, 2017
Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS EraIngrid G M Poodt, Pauline E R Spronk, Guusje Vugts, et al.
Annals of Surgical Oncology|March 22, 2020
Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer PatientsJulia E C van Steenhoven, Anne Kuijer, Marissa C van Maaren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2017
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort StudyAnne Kuijer, Marieke Straver, Bianca den Dekker, et al.
Annals of Surgical Oncology|April 21, 2021
Arm Morbidity After Local Therapy for Young Breast Cancer PatientsAnne Kuijer, Laura S Dominici, Shoshana M Rosenberg, et al.
Genes|May 19, 2018
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort StudyJulia E C van Steenhoven, Anne Kuijer, Paul J van Diest, et al.
Breast Cancer Research and Treatment|September 30, 2024
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort studyEline E F Verreck, Anne Kuijer, Julia E C van Steenhoven, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Cancer|December 16, 2022
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de-escalating approachJulia E C van Steenhoven, Marissa C van Maaren, Eline E F Verreck, et al.
Breast Cancer Research and Treatment|May 21, 2020
Patients' perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflictJulia E C van Steenhoven, Bianca M den Dekker, Anne Kuijer, et al.
Annals of Surgery|July 26, 2017
Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS EraIngrid G M Poodt, Pauline E R Spronk, Guusje Vugts, et al.
Annals of Surgical Oncology|March 22, 2020
Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer PatientsJulia E C van Steenhoven, Anne Kuijer, Marissa C van Maaren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2017
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort StudyAnne Kuijer, Marieke Straver, Bianca den Dekker, et al.
Annals of Surgical Oncology|April 21, 2021
Arm Morbidity After Local Therapy for Young Breast Cancer PatientsAnne Kuijer, Laura S Dominici, Shoshana M Rosenberg, et al.
Genes|May 19, 2018
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort StudyJulia E C van Steenhoven, Anne Kuijer, Paul J van Diest, et al.
Breast Cancer Research and Treatment|September 30, 2024
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort studyEline E F Verreck, Anne Kuijer, Julia E C van Steenhoven, et al.
Pageof 2